Literature DB >> 9343386

Reciprocal interference between the sequence-specific core and nonspecific C-terminal DNA binding domains of p53: implications for regulation.

M E Anderson1, B Woelker, M Reed, P Wang, P Tegtmeyer.   

Abstract

The tumor suppressor p53 has two DNA binding domains: a central sequence-specific domain and a C-terminal sequence-independent domain. Here, we show that binding of large but not small DNAs by the C terminus of p53 negatively regulates sequence-specific DNA binding by the central domain. Four previously described mechanisms for activation of specific DNA binding operate by blocking negative regulation. Deletion of the C terminus of p53 activates specific DNA binding only in the presence of large DNA. Three activator molecules (a small nucleic acid, a monoclonal antibody against the p53 C terminus, and a C-terminal peptide of p53) stimulate sequence-specific DNA binding only in the presence of both large DNA and p53 with an intact C terminus. Our findings argue that interactions of the C terminus of p53 with genomic DNA in vivo would prevent p53 binding to specific promoters and that cellular mechanisms to block C-terminal DNA binding would be required.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9343386      PMCID: PMC232476          DOI: 10.1128/MCB.17.11.6255

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  24 in total

1.  Regulation of the specific DNA binding function of p53.

Authors:  T R Hupp; D W Meek; C A Midgley; D P Lane
Journal:  Cell       Date:  1992-11-27       Impact factor: 41.582

2.  Formation of stable p53 homotetramers and multiples of tetramers.

Authors:  J E Stenger; G A Mayr; K Mann; P Tegtmeyer
Journal:  Mol Carcinog       Date:  1992       Impact factor: 4.784

3.  A transcriptionally active DNA-binding site for human p53 protein complexes.

Authors:  W D Funk; D T Pak; R H Karas; W E Wright; J W Shay
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Identification and analysis of all components of a gel retardation assay by combination with immunoblotting.

Authors:  S Demczuk; M Harbers; B Vennström
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

6.  p53 domains: suppression, transformation, and transactivation.

Authors:  M Reed; Y Wang; G Mayr; M E Anderson; J F Schwedes; P Tegtmeyer
Journal:  Gene Expr       Date:  1993

7.  Wild-type, but not mutant, human p53 proteins inhibit the replication activities of simian virus 40 large tumor antigen.

Authors:  P N Friedman; S E Kern; B Vogelstein; C Prives
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

8.  Identification of p53 as a sequence-specific DNA-binding protein.

Authors:  S E Kern; K W Kinzler; A Bruskin; D Jarosz; P Friedman; C Prives; B Vogelstein
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

9.  The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots.

Authors:  N P Pavletich; K A Chambers; C O Pabo
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

10.  Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants.

Authors:  T D Halazonetis; A N Kandil
Journal:  EMBO J       Date:  1993-12-15       Impact factor: 11.598

View more
  36 in total

1.  In vitro evolution of thermostable p53 variants.

Authors:  I Matsumura; A D Ellington
Journal:  Protein Sci       Date:  1999-04       Impact factor: 6.725

2.  p53 C-terminal interaction with DNA ends and gaps has opposing effect on specific DNA binding by the core.

Authors:  S B Zotchev; M Protopopova; G Selivanova
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

3.  Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein.

Authors:  Kristine McKinney; Carol Prives
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

4.  The structure of p53 tumour suppressor protein reveals the basis for its functional plasticity.

Authors:  Andrei L Okorokov; Michael B Sherman; Celia Plisson; Vera Grinkevich; Kristmundur Sigmundsson; Galina Selivanova; Jo Milner; Elena V Orlova
Journal:  EMBO J       Date:  2006-10-19       Impact factor: 11.598

5.  DNA damage activates p53 through a phosphorylation-acetylation cascade.

Authors:  K Sakaguchi; J E Herrera; S Saito; T Miki; M Bustin; A Vassilev; C W Anderson; E Appella
Journal:  Genes Dev       Date:  1998-09-15       Impact factor: 11.361

6.  Regulation of Mdm2-directed degradation by the C terminus of p53.

Authors:  M H Kubbutat; R L Ludwig; M Ashcroft; K H Vousden
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

Review 7.  The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein.

Authors:  Oleg Laptenko; David R Tong; James Manfredi; Carol Prives
Journal:  Trends Biochem Sci       Date:  2016-09-23       Impact factor: 13.807

8.  Recognition of RNA by the p53 tumor suppressor protein in the yeast three-hybrid system.

Authors:  Kasandra J-L Riley; Laura A Cassiday; Akash Kumar; L James Maher
Journal:  RNA       Date:  2006-04       Impact factor: 4.942

9.  Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).

Authors:  Ying Zhao; Shaoli Lu; Lipeng Wu; Guolin Chai; Haiying Wang; Yingqi Chen; Jia Sun; Yu Yu; Wen Zhou; Quanhui Zheng; Mian Wu; Gregory A Otterson; Wei-Guo Zhu
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

10.  Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities.

Authors:  Fuming Yi; Abhik Saha; Masanao Murakami; Pankaj Kumar; Jason S Knight; Qiliang Cai; Tathagata Choudhuri; Erle S Robertson
Journal:  Virology       Date:  2009-04-24       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.